Trilogy Technologies blood glucose and cholesterol device @ CES 2024

Published: Feb. 7, 2024, 2:32 p.m.

Non-invasive blood glucose monitoring is a new technology designed to simplify and enhance the convenience of monitoring blood glucose levels for individuals with diabetes. Trilogy Technologies, a company specializing in non-invasive medical devices, has developed a device that not only detects blood glucose levels but also measures uric acid and total cholesterol levels. This device \u2026 Continue reading Trilogy Technologies\u2019 blood glucose and cholesterol device @ CES 2024 \u2192

\n

The post Trilogy Technologies\u2019 blood glucose and cholesterol device @ CES 2024 appeared first on Tech Podcast Network.